Diabetes is a chronic illness that develops from a combination of genetics, diet and lifestyle. Too much sugar in the ...

The pharma giant said amycretin helped patients lose weight and reduce blood-sugar levels in pill and injection forms during ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression ...

Novo Nordisk's blockbuster weight loss drug semaglutide failed to slow Alzheimer's progression in trials. The studies had ...

The studies were a setback for the optimistic view that semaglutide and other drugs used in obesity and diabetes treatment could help prevent a number of brain diseases.

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the ...

The Food and Drug Administration is set to treat application under its priority program that seeks to accelerate the review ...

One of the most pressing health challenges facing Americans today is type 2 diabetes. More than 38 million people in the U.S. live with diabetes — that’s about 1 in ...

Novo Nordisk A/S said a next-generation diabetes shot lowered patients’ blood sugar and helped them lose weight in a study that may be a positive sign for the embattled drugmaker’s future portfolio.